Merit Historical Income Statement
MMSI Stock | USD 103.66 0.34 0.33% |
Historical analysis of Merit Medical income statement accounts such as Gross Profit of 613.1 M can show how well Merit Medical Systems performed in making a profits. Evaluating Merit Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Merit Medical's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Merit Medical Systems latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Merit Medical Systems is a good buy for the upcoming year.
Merit |
About Merit Income Statement Analysis
Merit Medical Systems Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Merit Medical shareholders. The income statement also shows Merit investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Merit Medical Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Merit Medical Systems generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Merit Medical Systems. It is also known as Merit Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Cost Of Revenue
Cost of Revenue is found on Merit Medical Systems income statement and represents the costs associated with goods and services Merit Medical provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Merit Medical income statement and is an important metric when analyzing Merit Medical Systems profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most accounts from Merit Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Merit Medical Systems current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. As of now, Merit Medical's Gross Profit is increasing as compared to previous years. The Merit Medical's current Other Operating Expenses is estimated to increase to about 1.2 B, while Total Other Income Expense Net is forecasted to increase to (11.3 M).
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 406.9M | 418.0M | 459.9M | 482.9M | Cost Of Revenue | 589.4M | 631.9M | 673.5M | 707.2M |
Merit Medical income statement Correlations
Click cells to compare fundamentals
Merit Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Merit Medical income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 104.4M | 106.8M | 95.8M | 92.2M | 101.3M | 106.4M | |
Interest Expense | 12.4M | 10.0M | 5.3M | 6.3M | 15.5M | 16.3M | |
Total Revenue | 994.9M | 963.9M | 1.1B | 1.2B | 1.3B | 1.3B | |
Gross Profit | 432.4M | 401.2M | 485.3M | 519.1M | 583.9M | 613.1M | |
Other Operating Expenses | 955.4M | 918.0M | 996.4M | 1.0B | 1.1B | 1.2B | |
Operating Income | (65.7M) | (62.6M) | 60.9M | 87.6M | 123.9M | 130.1M | |
Ebit | (65.7M) | (4.1M) | 57.7M | 89.0M | 130.2M | 136.7M | |
Ebitda | 38.6M | 102.7M | 153.5M | 181.2M | 231.4M | 243.0M | |
Cost Of Revenue | 562.5M | 562.7M | 589.4M | 631.9M | 673.5M | 707.2M | |
Total Operating Expenses | 392.9M | 355.3M | 406.9M | 418.0M | 459.9M | 482.9M | |
Income Before Tax | 2.2M | (13.2M) | 53.9M | 82.6M | 112.1M | 117.7M | |
Total Other Income Expense Net | 67.9M | (11.7M) | (7.0M) | (19.4M) | (11.9M) | (11.3M) | |
Net Income | 5.5M | (9.8M) | 48.5M | 74.5M | 94.4M | 99.1M | |
Income Tax Expense | (3.3M) | (3.4M) | 5.5M | 8.1M | 17.7M | 18.6M | |
Research Development | 65.6M | 57.5M | 71.2M | 75.5M | 82.7M | 86.9M | |
Selling General Administrative | 327.3M | 297.7M | 335.7M | 342.5M | 361.2M | 379.2M | |
Net Income Applicable To Common Shares | 5.5M | (9.8M) | 48.5M | 74.5M | 85.7M | 90.0M | |
Net Income From Continuing Ops | 5.5M | (9.8M) | 48.5M | 74.5M | 100.2M | 105.2M | |
Tax Provision | (3.3M) | (3.4M) | 5.5M | 8.1M | 10.6M | 11.1M | |
Interest Income | 291K | 604K | 769K | 439K | 656K | 958.0K | |
Net Interest Income | (12.7M) | (9.4M) | (4.5M) | (5.9M) | (12.0M) | (12.6M) | |
Reconciled Depreciation | 104.4M | 106.8M | 95.8M | 92.2M | 98.0M | 97.5M |
Currently Active Assets on Macroaxis
When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Merit Medical Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Merit Medical. If investors know Merit will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.091 | Earnings Share 2.05 | Revenue Per Share 22.847 | Quarterly Revenue Growth 0.078 | Return On Assets 0.0456 |
The market value of Merit Medical Systems is measured differently than its book value, which is the value of Merit that is recorded on the company's balance sheet. Investors also form their own opinion of Merit Medical's value that differs from its market value or its book value, called intrinsic value, which is Merit Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Merit Medical's market value can be influenced by many factors that don't directly affect Merit Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Merit Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Merit Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Merit Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.